IRIDEX Corp (IRIX.OQ)
IRIX.OQ on NASDAQ Stock Exchange Global Market
5.73USD
19 Apr 2018
5.73USD
19 Apr 2018
Change (% chg)
-- (--)
-- (--)
Prev Close
$5.73
$5.73
Open
--
--
Day's High
--
--
Day's Low
--
--
Volume
--
--
Avg. Vol
5,944
5,944
52-wk High
$11.73
$11.73
52-wk Low
$5.34
$5.34
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2017 | Dec '17 | 10.24 | -0.445 |
| Sep '17 | 10.86 | -0.268 | |
| Jul '17 | 10.00 | -0.238 | |
| Apr '17 | 10.48 | -0.162 | |
| FY 2016 | Dec '16 | 12.53 | -1.036 |
| Oct '16 | 9.79 | -0.066 | |
| Jul '16 | 11.91 | -0.033 | |
| Apr '16 | 11.93 | 0.010 |
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Jun-18 | 1 | 9.14 | 9.14 | 9.14 | 15.48 |
| Quarter Ending Sep-18 | 1 | 10.42 | 10.42 | 10.42 | 15.91 |
| Year Ending Dec-18 | 1 | 39.70 | 39.70 | 39.70 | 59.86 |
| Year Ending Dec-19 | 1 | 47.48 | 47.48 | 47.48 | 73.65 |
| Earnings (per share) | |||||
| Quarter Ending Jun-18 | 1 | -0.32 | -0.32 | -0.32 | 0.02 |
| Quarter Ending Sep-18 | 1 | -0.27 | -0.27 | -0.27 | 0.02 |
| Year Ending Dec-18 | 1 | -1.14 | -1.14 | -1.14 | -0.10 |
| Year Ending Dec-19 | 1 | -0.59 | -0.59 | -0.59 | -- |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
Dividends
Growth Rates
Financial Strength
Profitability Ratios
Efficiency
Management Effectiveness
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | 10.54 | 6.44 | 6.84 |
| EPS (TTM) % | -2,560.21 | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for IRIDEX Corp
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
- BRIEF-Iridex Announces Availability Of G-Probe Illuminate Device In Europe
- BRIEF-Iridex Qtrly Loss Per Share $0.44
- BRIEF-Iridex Issues Voluntary Recall Of Trufocus Lio Premiere Laser Indirect Ophthalmoscope
- BRIEF-Blueline Capital Partners LP Reports 8.5 pct Passive Stake In Iridex Corp As Of Dec. 31, 2017
- BRIEF-Iridex Corp Filed Lawsuit Against Quantel Medical S.A
Institutional Holders
| % Shares Owned: | 56.82% |
| # of Holders: | 43 |
| Total Shares Held: | 6,606,804 |
| 3 Mo. Net Change: | 222 |
| # New Positions: | 0 |
| # Closed Positions: | 0 |
| # Increased Positions: | 1 |
| # Reduced Positions: | 0 |
| # Net Buyers: | 1 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.